Paul Meier
Psychiatry · Richardson, TXNPI 1336226968
Payments from drug & device makers
Across 148 payments — averaging $15.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$820
- Johnson & Johnson$313
- Tris Pharma Inc$233
- Sunovion Pharmaceuticals Inc.$201
- Lundbeck LLC$111
- Neos Therapeutics, LP$110
- plus $504 from 15 others
What the payments were for
- Food & beverage$2,291100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 62 | $820 |
| Johnson & Johnson | 12 | $313 |
| Tris Pharma Inc | 20 | $233 |
| Sunovion Pharmaceuticals Inc. | 13 | $201 |
| Lundbeck LLC | 6 | $111 |
| Neos Therapeutics, LP | 6 | $110 |
| Corium, LLC | 5 | $106 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $92 |
| Almatica Pharma LLC | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| Idorsia Pharmaceuticals US Inc | 2 | $32 |
| Shire North American Group Inc | 2 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28 |
| Eisai Inc. | 2 | $28 |
| Jazz Pharmaceuticals Inc. | 1 | $23 |
| Neurocrine Biosciences, Inc. | 1 | $20 |
| Noven Therapeutics, LLC | 1 | $18 |
| Ironshore Pharmaceuticals Inc. | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Bausch Health US, LLC | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$129
How this compares
$2,291 in reported general payments places this provider in the 75th percentile of 2,238 psychiatry providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 65 | $2,395 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 26 | $892 |
| Clonazepam | 16 | $257 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Richardson
- Scott BartleyDallas$42.7M
- David BrownAustin$15.8M
- Rajinder ShiwachDesoto$15.4M
- Darin OkudaDallas$14.7M
- Jason MensahBeaumont$10.3M
- Michael DowningDallas$7.6M
- Rakesh JainLake Jackson$7.2M
- Suresh SureddiPlano$5.9M
- Marshall LucasThe Woodlands$4.8M
- Sejal MehtaPlano$3.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.